Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Vaccines
•
Allergy & Immunology
•
Primary Care
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Related Questions
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
How do you manage recurrent epistaxis from nasal steroids?
Do you use AIT as an adjunct therapy in addition to nasal sprays and oral medications for CRS?
How often do you find a food allergy on a skin test in an EoE patient that when avoided will result in significant resolution of EoE?
What is your experience managing patients with chronic spontaneous urticaria occurring only at night?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
Do you find that hydroxyzine worsens cognitive symptoms in patients who are already susceptible to cognitive impairment (i.e., schizophrenia, ADHD, dementia)?
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
